BioAtla stockholders elect directors, ratify auditor, approve say-on-pay at 2026 annual meeting

BioAtla, Inc.

Jay M. Short and Edward Williams elected as Class III directors with ~70% of votes cast (excluding broker non-votes).
Ernst & Young ratified as independent auditor for FY2026: 869,667 for, 18,545 against, 18,771 abstentions.
Non-binding advisory vote on executive compensation approved: 281,294 for, 96,492 against, 69,033 abstentions.
Approximately 55% of outstanding shares (906,983 shares) were represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.